These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 9413159)
21. Myogenin expression is necessary for commitment to differentiation and is closely related to src tyrosine kinase activity in quail myoblasts transformed with Rous sarcoma virus. Hirayama E; Isobe A; Okamoto H; Nishioka M; Kim J Eur J Cell Biol; 1997 Feb; 72(2):133-41. PubMed ID: 9157009 [TBL] [Abstract][Full Text] [Related]
22. Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1. Uehara Y; Murakami Y; Sugimoto Y; Mizuno S Cancer Res; 1989 Feb; 49(4):780-5. PubMed ID: 2463877 [TBL] [Abstract][Full Text] [Related]
23. [Protein kinase inhibitors--screening of new molecular target therapeutics]. Uehara Y Gan To Kagaku Ryoho; 1997 Jan; 24(2):136-44. PubMed ID: 9030224 [TBL] [Abstract][Full Text] [Related]
24. Method of identifying inhibitors of oncogenic transformation: selective inhibition of cell growth in serum-free medium. Li PM; Fukazawa H; Yamamoto C; Mizuno S; Tanaka K; Hori M; Yaginuma S; Saito T; Uehara Y Oncogene; 1993 Jul; 8(7):1731-5. PubMed ID: 8510919 [TBL] [Abstract][Full Text] [Related]
25. Phosphatidylinositol metabolism and polyoma-mediated transformation. Kaplan DR; Whitman M; Schaffhausen B; Raptis L; Garcea RL; Pallas D; Roberts TM; Cantley L Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3624-8. PubMed ID: 2424008 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors. Karni R; Jove R; Levitzki A Oncogene; 1999 Aug; 18(33):4654-62. PubMed ID: 10467412 [TBL] [Abstract][Full Text] [Related]
28. Protein-tyrosine kinase activity and pp60v-src expression in whole cells measured by flow cytometry. Preis PN; Waldman FM; Frackelton AR; Saya H; Levin VA Cancer Res; 1988 Aug; 48(16):4633-8. PubMed ID: 3135116 [TBL] [Abstract][Full Text] [Related]
29. Effects of herbimycin A derivatives on growth and differentiation of K562 human leukemic cells. Honma Y; Kasukabe T; Hozumi M; Shibata K; Omura S Anticancer Res; 1992; 12(1):189-92. PubMed ID: 1567167 [TBL] [Abstract][Full Text] [Related]
30. Effect of herbimycin A on renal cancer cell growth. Tsuji A; Asano T; Suzuki S; Aoyagi T; Hayakawa M; Nakamura H Nihon Jinzo Gakkai Shi; 1996 May; 38(5):198-201. PubMed ID: 8699609 [TBL] [Abstract][Full Text] [Related]
31. Analysis of pp60c-src protein kinase activity in hamster embryo cells transformed by simian virus 40, human adenoviruses, and bovine papillomavirus 1. Amini S; Lewis AM; Israel MA; Butel JS; Bolen JB J Virol; 1986 Jan; 57(1):357-61. PubMed ID: 2416954 [TBL] [Abstract][Full Text] [Related]
32. Intestinal crypt cells contain higher levels of cytoskeletal-associated pp60c-src protein tyrosine kinase activity than do differentiated enterocytes. Cartwright CA; Mamajiwalla S; Skolnick SA; Eckhart W; Burgess DR Oncogene; 1993 Apr; 8(4):1033-9. PubMed ID: 7681158 [TBL] [Abstract][Full Text] [Related]
33. Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo. Yoneda T; Lowe C; Lee CH; Gutierrez G; Niewolna M; Williams PJ; Izbicka E; Uehara Y; Mundy GR J Clin Invest; 1993 Jun; 91(6):2791-5. PubMed ID: 8514886 [TBL] [Abstract][Full Text] [Related]
34. Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. Cross-talk between G protein-coupled receptors and pp60c-src. Simonson MS; Herman WH J Biol Chem; 1993 May; 268(13):9347-57. PubMed ID: 7683650 [TBL] [Abstract][Full Text] [Related]
35. Isolation of a variant which has reduced Src activity from SH-SY5Y neuroblastoma cells. Hiwasa T; Nakamura Y; Sakiyama S Anticancer Res; 1998; 18(5A):3311-4. PubMed ID: 9858901 [TBL] [Abstract][Full Text] [Related]
36. Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma. Lutz MP; Esser IB; Flossmann-Kast BB; Vogelmann R; Lührs H; Friess H; Büchler MW; Adler G Biochem Biophys Res Commun; 1998 Feb; 243(2):503-8. PubMed ID: 9480838 [TBL] [Abstract][Full Text] [Related]
37. Association of p60fyn with middle tumor antigen in murine polyomavirus-transformed rat cells. Horak ID; Kawakami T; Gregory F; Robbins KC; Bolen JB J Virol; 1989 May; 63(5):2343-7. PubMed ID: 2539523 [TBL] [Abstract][Full Text] [Related]
38. Cell fractionation in non-ionic detergent distinguishes sub-populations of polyoma virus middle T antigen and reveals a novel form. Krauzewicz N; Elliott J; Griffin BE Oncogene; 1994 Aug; 9(8):2283-91. PubMed ID: 7518577 [TBL] [Abstract][Full Text] [Related]
40. Activation of the pp60c-src kinase by middle T antigen binding or by dephosphorylation. Courtneidge SA EMBO J; 1985 Jun; 4(6):1471-7. PubMed ID: 2411538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]